Maysa Vilbert

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 15

Top Topics

Systematic Review

Squamous Cell Carcinoma

Early Breast Cancer

Tyrosine Kinase

Top Venues

Journal of personalized medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Isabella Michelon, Maysa Vilbert, Caio Ernesto do Rego Castro, Carlos Stecca, Maria Inez Dacoregio, Manglio Rizzo, Vladmir Cláudio Cordeiro de Lima, Ludimila Cavalcante
EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cell Lung Cancer Patients Previously Exposed to EGFR-TKI: A Systematic Review and Meta-Analysis. Journal of personalized medicine 14 (7) (2024)
Jonathan N Priantti, Maysa Vilbert, Francisco Cezar Aquino de Moraes, Thiago Madeira, Evair Moisés de Lima Santiago, Natasha B Leighl, Ludimila Cavalcante, Nagla F Abdel Karim
Neurocognitive Adverse Events Related to Lorlatinib in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Cancers 16 (14) (2024)
Francisco Cezar Aquino de Moraes, Gustavo de Oliveira Almeida, Vinícius Freire Costa Alves, Jonathan N Priantti, Giovanna da Conceição Gomes, Sarah Vitória Bristot Carnevalli, Thiago Madeira, Maysa Vilbert, Carlos Stecca, Maria Cristina Figueroa Magalhães, Marianne Rodrigues Fernandes, Ney Pereira Carneiro Dos Santos
Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials. Journal of personalized medicine 14 (5) (2024)
Isabella Michelon, Maysa Vilbert, Caio Ernesto do Rego Castro, Carlos Stecca, Maria Inez Dacoregio, Manglio Rizzo, Vladmir Cláudio Cordeiro de Lima, Ludimila Cavalcante
EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cell Lung Cancer Patients Previously Exposed to EGFR-TKI: A Systematic Review and Meta-Analysis. Journal of personalized medicine 14 (7) (2024)
Jonathan N Priantti, Maysa Vilbert, Francisco Cezar Aquino de Moraes, Thiago Madeira, Evair Moisés de Lima Santiago, Natasha B Leighl, Ludimila Cavalcante, Nagla F Abdel Karim
Neurocognitive Adverse Events Related to Lorlatinib in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Cancers 16 (14) (2024)
Francisco Cezar Aquino de Moraes, Gustavo de Oliveira Almeida, Vinícius Freire Costa Alves, Jonathan N Priantti, Giovanna da Conceição Gomes, Sarah Vitória Bristot Carnevalli, Thiago Madeira, Maysa Vilbert, Carlos Stecca, Maria Cristina Figueroa Magalhães, Marianne Rodrigues Fernandes, Ney Pereira Carneiro Dos Santos
Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials. Journal of personalized medicine 14 (5) (2024)
Isabella Michelon, Maysa Vilbert, Caio Ernesto do Rego Castro, Carlos Stecca, Maria Inez Dacoregio, Manglio Rizzo, Vladmir Cláudio Cordeiro de Lima, Ludimila Cavalcante
EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cell Lung Cancer Patients Previously Exposed to EGFR-TKI: A Systematic Review and Meta-Analysis. Journal of personalized medicine 14 (7) (2024)
Jonathan N Priantti, Maysa Vilbert, Francisco Cezar Aquino de Moraes, Thiago Madeira, Evair Moisés de Lima Santiago, Natasha B Leighl, Ludimila Cavalcante, Nagla F Abdel Karim
Neurocognitive Adverse Events Related to Lorlatinib in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Cancers 16 (14) (2024)
Erica C Koch Hein, Maysa Vilbert, Ian Hirsch, Maurício Fernando Silva Almeida Ribeiro, Thiago P Muniz, Cynthia Fournier, Khaled Abdulalem, Erick Figueiredo Saldanha, Erika Martinez, Anna Spreafico, David H Hogg, Marcus O Butler, Samuel D Saibil
Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre. Cancers 15 (17) (2023)
Maysa Vilbert, Erica C Koch, April A N Rose, Rob C Laister, Diana Gray, Valentin Sotov, Susanne Penny, Anna Spreafico, Devanand M Pinto, Marcus O Butler, Samuel D Saibil
Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy. Cancers 15 (14) (2023)
Francisco Cezar Aquino de Moraes, Maysa Vilbert, Vinícius Freire Costa Alves, Gustavo de Oliveira Almeida, Jonathan N Priantti, Thiago Madeira, Carlos Stecca, Marianne Rodrigues Fernandes, Ney Pereira Carneiro Dos Santos
Mesenchymal-Epithelial Transition Kinase Inhibitor Therapy in Patients with Advanced Papillary Renal-Cell Carcinoma: A Systematic Review and Meta-Analysis. International journal of molecular sciences 24 (24) (2023)
Francisco Cezar Aquino de Moraes, Maysa Vilbert, Vinícius Freire Costa Alves, Gustavo de Oliveira Almeida, Jonathan N Priantti, Thiago Madeira, Carlos Stecca, Marianne Rodrigues Fernandes, Ney Pereira Carneiro Dos Santos
Mesenchymal-Epithelial Transition Kinase Inhibitor Therapy in Patients with Advanced Papillary Renal-Cell Carcinoma: A Systematic Review and Meta-Analysis. International journal of molecular sciences 24 (24) (2023)
Francisco Cezar Aquino de Moraes, Maysa Vilbert, Vinícius Freire Costa Alves, Gustavo de Oliveira Almeida, Jonathan N Priantti, Thiago Madeira, Carlos Stecca, Marianne Rodrigues Fernandes, Ney Pereira Carneiro Dos Santos
Mesenchymal-Epithelial Transition Kinase Inhibitor Therapy in Patients with Advanced Papillary Renal-Cell Carcinoma: A Systematic Review and Meta-Analysis. International journal of molecular sciences 24 (24) (2023)
Alireza Tojjari, Francis J Giles, Maysa Vilbert, Anwaar Saeed, Ludimila Cavalcante
SLAM Modification as an Immune-Modulatory Therapeutic Approach in Cancer. Cancers 15 (19) (2023)
Jonathan N Priantti, Maysa Vilbert, Thiago Madeira, Francisco Cezar A Moraes, Erica C Koch Hein, Anwaar Saeed, Ludimila Cavalcante
Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors in Advanced Melanoma Patients: A Systematic Review and Meta-Analysis. Cancers 15 (15) (2023)